Steadman Philippon Research Institute
12
5
8
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
25.0%
3 terminated/withdrawn out of 12 trials
25.0%
-61.5% vs industry average
0%
0 trials in Phase 3/4
200%
2 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Dynamic ACL Brace: In Vivo Kinematics
Role: lead
Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients
Role: collaborator
Home-Based Leg Dexterity Trainer for Management of Knee Osteoarthritis
Role: lead
Cold and Heat Investigation to Lower Levels of Depression
Role: collaborator
Investigation to Understand and Optimize Psilocybin
Role: collaborator
Senolytic Drugs Attenuate Osteoarthritis-Related Articular Cartilage Degeneration: A Clinical Trial
Role: lead
Prospective Evaluation of PRP and BMC Treatment to Accelerate Healing After ACL Reconstruction
Role: lead
Senolytic Agent Improve the Benefit of Platelet-Rich Plasma and Losartan
Role: lead
Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis
Role: lead
Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using Losartan
Role: lead
Losartan to Improve Hip Microfracture
Role: lead
BFR Therapy After ACL Reconstruction
Role: lead
All 12 trials loaded